187 related articles for article (PubMed ID: 32904265)
1. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.
Yoshida Y; Zhang XM; Wang H; Machida T; Mine S; Kobayashi E; Adachi A; Matsutani T; Kamitsukasa I; Wada T; Aotsuka A; Iwase K; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Shin H; Akaogi Y; Shimada J; Nishi E; Ohno M; Takemoto M; Yokote K; Kitamura K; Iwadate Y; Hiwasa T
Heliyon; 2020 Aug; 6(8):e04661. PubMed ID: 32904265
[TBL] [Abstract][Full Text] [Related]
2. Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.
Yoshida Y; Wang H; Hiwasa T; Machida T; Kobayashi E; Mine S; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Kamitsukasa I; Shin H; Wada T; Aotsuka A; Nishi E; Ohno M; Takemoto M; Yokote K; Takahashi S; Matsushima J; Zhang XM; Takiguchi M; Iwadate Y
Oncotarget; 2018 Feb; 9(10):8836-8848. PubMed ID: 29507658
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
Hiwasa T; Wang H; Goto KI; Mine S; Machida T; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kunimatsu M; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Muto M; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Hattori A; Yamamoto M; Maezawa Y; Kobayashi K; Ishibashi R; Takemoto M; Yokote K; Takizawa H; Kishimoto T; Matsushita K; Kobayashi S; Nomura F; Arasawa T; Kagaya A; Maruyama T; Matsubara H; Tomiita M; Hamanaka S; Imai Y; Nakagawa T; Kato N; Terada J; Matsumura T; Katsumata Y; Naito A; Tanabe N; Sakao S; Tatsumi K; Ito M; Shiratori F; Sumazaki M; Yajima S; Shimada H; Shirouzu M; Yokoyama S; Kudo T; Doi H; Iwase K; Ashino H; Li SY; Kubota M; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y
BMC Med; 2021 Jun; 19(1):131. PubMed ID: 34103026
[TBL] [Abstract][Full Text] [Related]
4. Elevation of Autoantibody in Patients with Ischemic Stroke.
Yoshida Y; Hiwasa T; Machida T; Kobayashi E; Mine S; Matsushima J; Takiguchi M; Iwadate Y
Neurol Med Chir (Tokyo); 2018 Jul; 58(7):303-310. PubMed ID: 29848906
[TBL] [Abstract][Full Text] [Related]
5. Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.
Wang H; Lu H; Zhang XM; Goto KI; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kamitsukasa I; Wada T; Aotsuka A; Sugimoto K; Takizawa H; Kashiwado K; Shin H; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Xu A; Hiwasa T
BMC Neurol; 2021 Jul; 21(1):274. PubMed ID: 34243715
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.
Namiki T; Takemoto M; Hayashi A; Yamagata H; Ishikawa T; Yokote K; Li SY; Kubota M; Zhang BS; Yoshida Y; Matsutani T; Mine S; Machida T; Kobayashi Y; Terada J; Naito A; Tatsumi K; Takizawa H; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
BMC Endocr Disord; 2023 Oct; 23(1):239. PubMed ID: 37904164
[TBL] [Abstract][Full Text] [Related]
7. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.
Wang H; Zhang XM; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Kimura R; Mine S; Kamitsukasa I; Wada T; Aotsuka A; Yoshida Y; Kobayashi E; Matsutani T; Iwadate Y; Sugimoto K; Mori M; Uzawa A; Muto M; Kuwabara S; Takemoto M; Kobayashi K; Kawamura H; Ishibashi R; Yokote K; Ohno M; Chen PM; Nishi E; Ono K; Kimura T; Machida T; Takizawa H; Kashiwado K; Shimada H; Ito M; Goto KI; Iwase K; Ashino H; Taira A; Arita E; Takiguchi M; Hiwasa T
Oncotarget; 2018 Jan; 9(5):5600-5613. PubMed ID: 29464021
[TBL] [Abstract][Full Text] [Related]
8. Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
Sumazaki M; Shimada H; Ito M; Shiratori F; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Takizawa H; Kashiwado K; Shin H; Kishimoto T; Matsushita K; Kobayashi S; Nakamura R; Shinmen N; Kuroda H; Zhang XM; Wang H; Goto KI; Hiwasa T
Cancer Sci; 2020 Dec; 111(12):4453-4464. PubMed ID: 32939876
[TBL] [Abstract][Full Text] [Related]
9. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.
Li SY; Yoshida Y; Kubota M; Zhang BS; Matsutani T; Ito M; Yajima S; Yoshida K; Mine S; Machida T; Hayashi A; Takemoto M; Yokote K; Ohno M; Nishi E; Kitamura K; Kamitsukasa I; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Iwase K; Shimada H; Iwadate Y; Hiwasa T
Front Cardiovasc Med; 2023; 10():1042272. PubMed ID: 36844744
[TBL] [Abstract][Full Text] [Related]
10. Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
Li SY; Yoshida Y; Kobayashi E; Adachi A; Hirono S; Matsutani T; Mine S; Machida T; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Kitamura K; Sumazaki M; Ito M; Shimada H; Takizawa H; Kashiwado K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Zhang XM; Wang H; Goto K; Iwadate Y; Hiwasa T
Int J Mol Med; 2020 Oct; 46(4):1274-1288. PubMed ID: 32945427
[TBL] [Abstract][Full Text] [Related]
11. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
Zhang BS; Zhang XM; Ito M; Yajima S; Yoshida K; Ohno M; Nishi E; Wang H; Li SY; Kubota M; Yoshida Y; Matsutani T; Mine S; Machida T; Takemoto M; Yamagata H; Hayashi A; Yokote K; Kobayashi Y; Takizawa H; Kuroda H; Shimada H; Iwadate Y; Hiwasa T
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732153
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction.
Kubota M; Yoshida Y; Kobayashi E; Matsutani T; Li SY; Zhang BS; Mine S; Machida T; Takizawa H; Hiwasa T; Iwadate Y
Sci Rep; 2021 Nov; 11(1):21772. PubMed ID: 34741085
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.
Li SY; Yoshida Y; Kobayashi E; Kubota M; Matsutani T; Mine S; Machida T; Maezawa Y; Takemoto M; Yokote K; Kobayashi Y; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kobayashi S; Matsushita K; Nomura F; Matsubara H; Sumazaki M; Ito M; Yajima S; Shimada H; Iwase K; Ashino H; Wang H; Goto K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
Sci Rep; 2021 Jun; 11(1):13450. PubMed ID: 34188129
[TBL] [Abstract][Full Text] [Related]
14. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.
Hu L; Liu J; Shimada H; Ito M; Sugimoto K; Hiwasa T; Zhou Q; Li J; Shen S; Wang H
Front Oncol; 2022; 12():870086. PubMed ID: 35656505
[TBL] [Abstract][Full Text] [Related]
15. Acute Ischemic Stroke and Transient Ischemic Attack in ST-Segment Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention.
Murakami T; Sakakura K; Jinnouchi H; Taniguchi Y; Tsukui T; Watanabe Y; Yamamoto K; Seguchi M; Wada H; Fujita H
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769488
[TBL] [Abstract][Full Text] [Related]
16. Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosis-Related Coronary Artery Disease, Cerebral Infarction and Diabetes Mellitus.
Hiwasa T; Zhang XM; Kimura R; Ohno M; Chen PM; Nishi E; Ono K; Kimura T; Kamitsukasa I; Wada T; Aotsuka A; Mine S; Takizawa H; Kashiwado K; Takemoto M; Kobayashi K; Kawamura H; Ishibashi R; Yokote K; Nakamura R; Tomiyoshi G; Shinmen N; Kuroda H
J Circ Biomark; 2016; 5():8. PubMed ID: 28936256
[TBL] [Abstract][Full Text] [Related]
17. DNAJC2 is reversely regulated by miR‑627‑3p, promoting the proliferation of colorectal cancer.
Liu H; Li J; Zhao H; Liu X; Ye X
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165158
[TBL] [Abstract][Full Text] [Related]
18. Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX).
Machida T; Kubota M; Kobayashi E; Iwadate Y; Saeki N; Yamaura A; Nomura F; Takiguchi M; Hiwasa T
J Transl Med; 2015 Feb; 13():71. PubMed ID: 25890248
[TBL] [Abstract][Full Text] [Related]
19. Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage.
Schaub F; Polymeris AA; Schaedelin S; Hert L; Meya L; Thilemann S; Traenka C; Wagner B; Seiffge D; Gensicke H; De Marchis GM; Bonati L; Engelter ST; Peters N; Lyrer P
J Am Heart Assoc; 2022 Jan; 11(1):e023345. PubMed ID: 34935409
[TBL] [Abstract][Full Text] [Related]
20. Anti-FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma.
Kobayashi S; Hiwasa T; Ishige T; Rahmutulla B; Kano M; Hoshino T; Minamoto T; Shimada H; Nomura F; Matsubara H; Matsushita K
Cancer Sci; 2019 Jun; 110(6):2004-2013. PubMed ID: 30980774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
